Phase 2 Gram-negative Bacterial Infection Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
Gram-negative Bacterial Infection
Pfizer48 enrolled29 locationsNCT06462235
Recruiting
Phase 2
Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
Gram-Negative Bacterial Infections
Pfizer48 enrolled24 locationsNCT05639647
Recruiting
Phase 2
Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV
Gram Negative PneumoniaGram-Negative Bacterial InfectionsBacteremia Caused by Gram-Negative Bacteria
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation234 enrolled2 locationsNCT06135350